Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2017 (LINC02017)

Target
LINC02017
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2017 (LINC02017) is a human long intergenic non-coding RNA (lincRNA), meaning it is a non-protein-coding transcript greater than 200 nucleotides in length, located in intergenic regions of the genome (those not overlapping protein-coding genes). lincRNAs in general are thought to have roles in regulating gene expression at multiple levels, including chromatin states, transcription, and post-transcriptional processes, but the specific biological roles, disease associations, and interactions of LINC02017 are currently not defined in the scientific literature. LINC02017 is cataloged in major gene databases (GeneCards, NCBI Gene, Ensembl), but lacks functional, disease, or drug interaction annotation, reflecting the general challenge of lincRNA characterization in human genomics. If detailed therapeutic or mechanistic context for LINC02017 becomes available in the future, this classification should be revisited.

Other names
LINC02017
02

Mechanism of action

Not applicable (no drugs target LINC02017)

03

Biological functions

Likely involved in gene expression regulation (specific function for LINC02017 not established in literature, but lincRNAs generally regulate transcription, chromatin state, and can act in cis or trans)Other (due to limited annotation for this specific lncRNA)
04

Disease associations

Other (no specific disease association for LINC02017 reported in curated sources; lincRNAs as a class are implicated in cancer, neurological disorders, and other diseases, but LINC02017-specific data are lacking)
05

Safety considerations

None reported (not a therapeutic or diagnostic target)
06

Interacting drugs

None reported
07

Biomarkers

None established (LINC02017 is not referenced as a clinical or research biomarker)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2017 (LINC02017).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2017 (LINC02017).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call